Clinical Trial Update: Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and immunogenicity of a serum-free DTaP-IPVvero combination vaccine, completed with results reported by Statens Serum Instit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTaP-IPVvero vaccine (Diphtheria and tetanus toxoids, acellular pertussis vaccine, and inactivated poliovirus vaccine (serum-free formulation))

Snippet

Sponsor: Statens Serum Institut | Conditions: Active Immunization | Phase 3 | Status: COMPLETED